Eversept Partners’s Cigna CI Stock Holding History

Eversept Partners’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-41,745	Closed	-$9.9M	–	111
2021 Q2	$9.9M	Buy	41,745 +1,745	+4%	+$436K	0.66%	36
2021 Q1	$9.67M	Buy	+40,000	New	+$8.92M	0.5%	41

Other funds holding CI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eversept Partners's CI Position: Q3 2021 in Review

Eversept Partners sold out of Cigna (CI) in Q3 2021, closing a stake of 41,745 shares — an estimated $9.9M sold.

Eversept Partners first reported a position in CI in Q1 2021 and held it in 2 quarters. The position peaked at $9.9M in Q2 2021. 1,248 funds tracked by Wall St. Rank hold CI as of Q3 2021.

Eversept Partners reported no remaining Cigna position as of Q3 2021 after selling out during the quarter.
Eversept Partners sold 41,745 Cigna shares in Q3 2021, an estimated $9.9M.
Eversept Partners first reported a position in Cigna in Q1 2021 and held it in 2 quarters.
Eversept Partners's Cigna position peaked at $9.9M in Q2 2021.
1,248 funds tracked by Wall St. Rank held Cigna as of Q3 2021.

Based on Eversept Partners's 13F filing for Q3 2021, filed 15 Nov 2021.